Next-Gen Immunotherapy Insights from High-Dose IL-2 Pharmacodynamics in Renal Cancer
The following is a summary of "Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2–Based Immunotherapies," published in the May 2024 issue of Allergy &...